ResMed Inc. (RMD)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 32.07B |
| Enterprise Value | 33.26B |
| Trailing P/E | 36.10 |
| Forward P/E | 27.40 |
| PEG Ratio (5 yr expected) | 2.06 |
| Price/Sales (ttm) | 7.14 |
| Price/Book (mrq) | 7.16 |
| Enterprise Value/Revenue | 7.38 |
| Enterprise Value/EBITDA | 23.26 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.67 |
| 52-Week Change 3 | -6.98% |
| S&P500 52-Week Change 3 | 22.36% |
| 52 Week High 3 | 240.09 |
| 52 Week Low 3 | 132.24 |
| 50-Day Moving Average 3 | 186.76 |
| 200-Day Moving Average 3 | 172.35 |
Share Statistics
| Avg Vol (3 month) 3 | 1.07M |
| Avg Vol (10 day) 3 | 1.58M |
| Shares Outstanding 5 | 147.09M |
| Implied Shares Outstanding 6 | 147.09M |
| Float 8 | 145.52M |
| % Held by Insiders 1 | 0.82% |
| % Held by Institutions 1 | 58.73% |
| Shares Short (Apr 15, 2024) 4 | 7.95M |
| Short Ratio (Apr 15, 2024) 4 | 7.89 |
| Short % of Float (Apr 15, 2024) 4 | 6.16% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 5.40% |
| Shares Short (prior month Mar 15, 2024) 4 | 7.66M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 1.92 |
| Forward Annual Dividend Yield 4 | 0.88% |
| Trailing Annual Dividend Rate 3 | 1.88 |
| Trailing Annual Dividend Yield 3 | 1.02% |
| 5 Year Average Dividend Yield 4 | 0.87 |
| Payout Ratio 4 | 30.46% |
| Dividend Date 3 | Mar 14, 2024 |
| Ex-Dividend Date 4 | May 08, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Aug 31, 2010 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Jun 30, 2021 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 20.91% |
| Operating Margin (ttm) | 31.29% |
Management Effectiveness
| Return on Assets (ttm) | 11.91% |
| Return on Equity (ttm) | 22.39% |
Income Statement
| Revenue (ttm) | 4.58B |
| Revenue Per Share (ttm) | 31.17 |
| Quarterly Revenue Growth (yoy) | 7.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.44B |
| Net Income Avi to Common (ttm) | 958.38M |
| Diluted EPS (ttm) | 6.04 |
| Quarterly Earnings Growth (yoy) | 29.20% |
Balance Sheet
| Total Cash (mrq) | 237.91M |
| Total Cash Per Share (mrq) | 1.62 |
| Total Debt (mrq) | 1.17B |
| Total Debt/Equity (mrq) | 25.21% |
| Current Ratio (mrq) | 3.04 |
| Book Value Per Share (mrq) | 31.50 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.2B |
| Levered Free Cash Flow (ttm) | 934.32M |
© 2024 Yahoo. All rights reserved.